Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Helen E. Heslop; Edward A. Stadtmauer; John E. Levine; Karen K. Ballen; Yi Bin Chen; Amy E. DeZern; Mary Eapen; Mehdi Hamadani; Betty K. Hamilton; Parameswaran Hari; Richard J. Jones; Brent R. Logan; Leslie S. Kean; Eric S. Leifer; Frederick L. Locke; Richard T. Maziarz; Eneida R. Nemecek; Marcelo Pasquini; Rachel Phelan; Marcie L. Riches; Bronwen E. Shaw; Mark C. Walters; Amy Foley; Steven M. Devine; Mary M. Horowitz

doi:10.1016/j.jtct.2021.08.016

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Helen E. Heslop, Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi Bin Chen, Amy E. DeZern, Mary Eapen, Mehdi Hamadani, Betty K. Hamilton, Parameswaran Hari, Richard J. Jones, Brent R. Logan, Leslie S. Kean, Eric S. Leifer, Frederick L. Locke, Richard T. Maziarz, Eneida R. Nemecek, Marcelo Pasquini, Rachel Phelan, Marcie L. RichesBronwen E. Shaw, Mark C. Walters, Amy Foley, Steven M. Devine, Mary M. Horowitz

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.

Original language	English
Pages (from-to)	885-907
Number of pages	23
Journal	Transplantation and Cellular Therapy
Volume	27
Issue number	11
DOIs	https://doi.org/10.1016/j.jtct.2021.08.016
State	Published - Nov 2021

Keywords

BMT
Cell Therapy
Clinical Trial

Access to Document

10.1016/j.jtct.2021.08.016

Cite this

Heslop, H. E., Stadtmauer, E. A., Levine, J. E., Ballen, K. K., Chen, Y. B., DeZern, A. E., Eapen, M., Hamadani, M., Hamilton, B. K., Hari, P., Jones, R. J., Logan, B. R., Kean, L. S., Leifer, E. S., Locke, F. L., Maziarz, R. T., Nemecek, E. R., Pasquini, M., Phelan, R., ... Horowitz, M. M. (2021). Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. Transplantation and Cellular Therapy, 27(11), 885-907. https://doi.org/10.1016/j.jtct.2021.08.016

@article{44c48db8644546ceae2cfc49479f7ee7,

title = "Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year",

abstract = "In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.",

keywords = "BMT, Cell Therapy, Clinical Trial",

author = "Heslop, \{Helen E.\} and Stadtmauer, \{Edward A.\} and Levine, \{John E.\} and Ballen, \{Karen K.\} and Chen, \{Yi Bin\} and DeZern, \{Amy E.\} and Mary Eapen and Mehdi Hamadani and Hamilton, \{Betty K.\} and Parameswaran Hari and Jones, \{Richard J.\} and Logan, \{Brent R.\} and Kean, \{Leslie S.\} and Leifer, \{Eric S.\} and Locke, \{Frederick L.\} and Maziarz, \{Richard T.\} and Nemecek, \{Eneida R.\} and Marcelo Pasquini and Rachel Phelan and Riches, \{Marcie L.\} and Shaw, \{Bronwen E.\} and Walters, \{Mark C.\} and Amy Foley and Devine, \{Steven M.\} and Horowitz, \{Mary M.\}",

note = "Publisher Copyright: {\textcopyright} 2021 The American Society for Transplantation and Cellular Therapy",

year = "2021",

month = nov,

doi = "10.1016/j.jtct.2021.08.016",

language = "English",

volume = "27",

pages = "885--907",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6375",

publisher = "Elsevier B.V.",

number = "11",

}

Heslop, HE, Stadtmauer, EA, Levine, JE, Ballen, KK, Chen, YB, DeZern, AE, Eapen, M, Hamadani, M, Hamilton, BK, Hari, P, Jones, RJ, Logan, BR, Kean, LS, Leifer, ES, Locke, FL, Maziarz, RT, Nemecek, ER, Pasquini, M, Phelan, R, Riches, ML, Shaw, BE, Walters, MC, Foley, A, Devine, SM & Horowitz, MM 2021, 'Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year', Transplantation and Cellular Therapy, vol. 27, no. 11, pp. 885-907. https://doi.org/10.1016/j.jtct.2021.08.016

TY - JOUR

T1 - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021

T2 - Looking Forward as the Network Celebrates its 20th Year

AU - Heslop, Helen E.

AU - Stadtmauer, Edward A.

AU - Levine, John E.

AU - Ballen, Karen K.

AU - Chen, Yi Bin

AU - DeZern, Amy E.

AU - Eapen, Mary

AU - Hamadani, Mehdi

AU - Hamilton, Betty K.

AU - Hari, Parameswaran

AU - Jones, Richard J.

AU - Logan, Brent R.

AU - Kean, Leslie S.

AU - Leifer, Eric S.

AU - Locke, Frederick L.

AU - Maziarz, Richard T.

AU - Nemecek, Eneida R.

AU - Pasquini, Marcelo

AU - Phelan, Rachel

AU - Riches, Marcie L.

AU - Shaw, Bronwen E.

AU - Walters, Mark C.

AU - Foley, Amy

AU - Devine, Steven M.

AU - Horowitz, Mary M.

PY - 2021/11

Y1 - 2021/11

N2 - In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.

AB - In 2021 the BMT CTN held the 4th State of the Science Symposium where the deliberations of 11 committees concerning major topics pertinent to a particular disease, modality, or complication of transplant, as well as two committees to consider clinical trial design and inclusion, diversity, and access as cross-cutting themes were reviewed. This article summarizes the individual committee reports and their recommendations on the highest priority questions in hematopoietic stem cell transplant and cell therapy to address in multicenter trials.

KW - BMT

KW - Cell Therapy

KW - Clinical Trial

UR - https://www.scopus.com/pages/publications/85116810681

U2 - 10.1016/j.jtct.2021.08.016

DO - 10.1016/j.jtct.2021.08.016

M3 - Review article

C2 - 34461278

AN - SCOPUS:85116810681

SN - 2666-6375

VL - 27

SP - 885

EP - 907

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 11

ER -

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Abstract

Keywords

Access to Document

Fingerprint

Cite this